MedPath

Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy

Not Applicable
Completed
Conditions
Bladder Cancer
Interventions
Dietary Supplement: Multivitamin
Dietary Supplement: Ensure Plus®
Registration Number
NCT02050451
Lead Sponsor
Vanderbilt University
Brief Summary

The current study is designed to assess the impact of an enriched oral nutritional shake (Ensure Plus®) to improve the nutritional status and patient outcome after surgery to remove a cancerous bladder (radical cystectomy). Radical cystectomy with urinary diversion using a segment of intestine is the standard of care for invasive bladder cancer. This operation has a high complication rate and several studies have shown that this may be directly related to poor nutrition.

The investigators believe that patients who consume an enriched nutritional shake before and after surgery will improve their nutrition status and experience fewer complications, shorter length of stay and less readmissions compared to those who do not.

Patients who are scheduled to undergo elective radical cystectomy will be eligible for enrollment. Once enrolled, they will be randomly assigned to one of two groups. One group will be offered Ensure Plus® twice daily for 2 weeks before and 4 weeks after their surgery and the other will be offered a daily over-the-counter multivitamin for the same period of time. The investigators will follow both groups for up to 30 days after their surgery and compare clinical outcomes such as: complication rates, length of stay, readmission rates and mortality as well as measure serum markers of nutrition status and assess changes in body composition.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • all patients eligible for elective radical cystectomy for bladder cancer at the sponsoring institution
Exclusion Criteria
  • inability to tolerate oral supplementation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlMultivitaminOver the counter daily multivitamin for 2 weeks before and 4 weeks after surgery
Nutrition InterventionEnsure Plus®Ensure Plus®, consumed orally twice daily for 2 weeks before and 4 weeks after surgery
Primary Outcome Measures
NameTimeMethod
Hospital-free days (HFDs)30 days

The study is powered to detect a difference in the number of HFDs over a 30 day period between intervention and control groups

Secondary Outcome Measures
NameTimeMethod
Complications30 days

The investigators will compare the difference in rate, type and severity of post-operative complications between groups

Length of stay30 days

The investigators will compare the length of stay following surgery between the two groups

Body composition30 days

The investigators will measure difference in lean body mass and fat mass between intervention and controls using whole body dual energy X-ray absorptiometry (DEXA) scan

Calories30 days

The investigators will compare caloric and nutrient intake between groups using comprehensive dietary assessment tools

Serum markers30 days

The investigators will compare serum levels of albumin, prealbumin, transferrin and retinol binding protein and C-reactive protein between groups

Tolerability / compliance30 days

The investigators will assess the patients' ability to tolerate and comply with the nutrition intervention

Readmission rate30 days

The investigators will compare the rate of readmissions over the 30 day postoperative period between intervention and control

Mortality30 days

The investigators will compare overall survival between groups over the 30 day postoperative period

Trial Locations

Locations (1)

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath